Genetesis Stock

genetesis.com/Healthcare / BioTech & PharmaFounded: 2013

Genetesis is a biopharma company focusing on the treatment of heart diseases and chest pain using digital and electric imaging technology. Genetesis has developed its Cardioflux imaging device, in which a patient can pass through, and by using magnetocardiography, it can pick up natural magnetic signals produced in the heart for optimal treatment and diagnosis options. Genetesis partners with healthcare organizations to bring its devices to the patients that could benefit from this type of cardiac care.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Genetesis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Genetesis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Genetesis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Genetesis investors also invested in these private companies

Mithril Capital Mangement
Ohio Innovation Fund
JobsOhio Growth Capital Fund
CincyTech

Team

Management Team

Peeyush Shrivastava
Co-Founder & Chief Executive Officer
Vineet Erasaia
Co-Founder & Chief Operations Officer
Emmanuel Setegn
Co-Founder & Chief Technology Officer
John Emanuel
Chief Financial Officer
Robert Takla
Chief Medical Officer

Board Members

John Rice, PhD
CincyTech
Anil Achyuta, PhD
TDK Ventures
Sajid Malhotra
Limelight Networks
Bill Baumel
Ohio Innovation Fund
Mark Cuban
Independent Director

Genetesis stock FAQs

plusminus

Can you buy Genetesis stock?

As Genetesis is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Genetesis, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Genetesis stock?

To invest in a private company like Genetesis through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Genetesis stock?

Yes, you may be able to sell your Genetesis stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Genetesis stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Genetesis stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Genetesis a public company?

No, Genetesis is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Genetesis’ stock price?

Genetesis is a privately held company and therefore does not have a public stock price. However, you may access Genetesis’ private market stock price with Forge Data.
plusminus

What is Genetesis’ stock ticker symbol?

Genetesis does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from Cercano Management as well as from existing investors, including JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.